Literature DB >> 25249047

Comment on: prescribing of rosiglitazone and pioglitazone following safety signals analysis of trends in dispensing patterns in The Netherlands from 1998 to 2008.

Eduardo Carracedo-Martínez1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25249047     DOI： 10.1007/s40264-014-0227-y

Source DB:  PubMed          Journal:  Drug Saf        ISSN： 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  3 in total

1.  Impact of a health safety warning and prior authorisation on the use of piroxicam: a time-series study.

Authors:  Eduardo Carracedo-Martínez; Agustin Pia-Morandeira; Adolfo Figueiras
Journal:  Pharmacoepidemiol Drug Saf       Date:  2012-01-10       Impact factor: 2.890

2.  Prescribing of rosiglitazone and pioglitazone following safety signals: analysis of trends in dispensing patterns in the Netherlands from 1998 to 2008.

Authors:  Rikje Ruiter; Loes E Visser; Myrthe P P van Herk-Sukel; Petronella H Geelhoed-Duijvestijn; Sandra de Bie; Sabine M J M Straus; Peter G M Mol; Silvana A Romio; Ron M C Herings; Bruno H Ch Stricker
Journal:  Drug Saf       Date:  2012-06-01       Impact factor: 5.606

3.  Prescribing pattern of glucose lowering drugs in the United Kingdom in the last decade: a focus on the effects of safety warnings about rosiglitazone.

Authors:  Ingrid Leal; Silvana A Romio; Martijn Schuemie; Alessandro Oteri; Miriam Sturkenboom; Gianluca Trifirò
Journal:  Br J Clin Pharmacol       Date:  2013-03       Impact factor: 4.335
  3 in total
  1 in total

1.  Influence of health warnings on the use of rosiglitazone and pioglitazone in an area of Spain: A time-series study.

Authors:  Eduardo Carracedo-Martínez; Agustin Pia-Morandeira
Journal:  SAGE Open Med       Date:  2016-08-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.